FDA Approved: ZELBORAF — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Zelboraf (vemurafenib) submitted by Genentech, Inc. The action updates the drug’s labeling based on data provided wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Zelboraf (vemurafenib)

Snippet

SUPPL AP for ZELBORAF (VEMURAFENIB)